Nephro Care Complete Financial Statements
NEPHROCARE • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Nephro Care (NEPHROCARE).
Downloads include all available records across all periods.
For market performance, see the
NEPHROCARE stock price today
.
Profitability Ratios
Net Profit Margin
8.33%
2025 data
EBITDA Margin
14.58%
2025 data
Operating Margin
13.00%
2025 data
Return on Assets
5.88%
2025 data
Return on Equity
7.41%
2025 data
Balance Sheet Ratios
Current Ratio
28.00
2025 data
Debt to Equity
1.26
2025 data
Equity Ratio
79.41%
2025 data
Asset Turnover
0.71
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-70.8%
Year-over-Year
Net Profit Growth
-75.0%
Year-over-Year
EBITDA Growth
-57.1%
Year-over-Year
Expense Growth
-70.0%
Year-over-Year
Assets Growth
+223.8%
Year-over-Year
Equity Growth
+260.0%
Year-over-Year
Liabilities Growth
+223.8%
Year-over-Year
Operating Cash Flow Growth
+700.0%
Year-over-Year
Investing Cash Flow Growth
-400.0%
Year-over-Year
Financing Cash Flow Growth
+483.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 14 | 48 | 28 | 17 | 3 | 2 | 1 |
| Expenses | 12 | 40 | 21 | 14 | 3 | 2 | 1 |
| EBITDA | 3 | 7 | 7 | 3 | 0 | 0 | 0 |
| Operating Profit Margin % | 10.00% | 13.00% | 24.00% | 20.00% | 4.00% | 10.00% | 2.00% |
| Depreciation | 1 | 3 | 1 | 1 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 5 | 6 | 3 | 0 | 0 | 0 |
| Tax | 2 | 1 | 2 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 4 | 5 | 2 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.80 | 2.38 | 3.80 | 2.37 | -0.03 | 135.15 | -14.78 |
Related Pages for Nephro Care
Additional stock information and data for NEPHROCARE
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 68 | 21 | 8 | 5 | 1 | 1 |
| Current Assets | 28 | 11 | 3 | 1 | 1 | 0 |
| Fixed Assets | 32 | 5 | 3 | 1 | 1 | 1 |
| Capital Work in Progress | 1 | 1 | 0 | 2 | 0 | 0 |
| Investments | 16 | 7 | 0 | 0 | 0 | 0 |
| Other Assets | 20 | 9 | 5 | 1 | 1 | 0 |
| LIABILITIES | ||||||
| Total Liabilities | 68 | 21 | 8 | 5 | 1 | 1 |
| Current Liabilities | 1 | 0 | 2 | 3 | 1 | 0 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 54 | 15 | 3 | 1 | 0 | 0 |
| Share Capital | 17 | 12 | 1 | 1 | 0 | 0 |
| Reserves & Surplus | 37 | 3 | 2 | 0 | 0 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 8 | 1 | 4 | 1 | 0 |
| Investing Activities | -40 | -8 | -2 | -3 | 0 |
| Financing Activities | 35 | 6 | 0 | 2 | 0 |
| Net Cash Flow | 3 | -1 | 2 | 0 | 0 |